Does It Matter How Hypertension Is Controlled?

被引:22
作者
Chobanian, Aram V. [1 ,2 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[2] Boston Univ, Med Ctr, Boston, MA 02118 USA
关键词
D O I
10.1056/NEJMe0808690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2485 / 2488
页数:5
相关论文
共 15 条
  • [1] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
  • [2] [Anonymous], HEART DIS STROK STAT
  • [3] Treatment of hypertension in patients 80 years of age or older
    Beckett, Nigel S.
    Peters, Ruth
    Fletcher, Astrid E.
    Staessen, Jan A.
    Liu, Lisheng
    Dumitrascu, Dan
    Stoyanovsky, Vassil
    Antikainen, Riitta L.
    Nikitin, Yuri
    Anderson, Craig
    Belhani, Alli
    Forette, Francoise
    Rajkumar, Chakravarthi
    Thijs, Lutgarde
    Banya, Winston
    Bulpitt, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) : 1887 - 1898
  • [4] ANTIATHEROGENIC EFFECT OF CAPTOPRIL IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT
    CHOBANIAN, AV
    HAUDENSCHILD, CC
    NICKERSON, C
    DRAGO, R
    [J]. HYPERTENSION, 1990, 15 (03) : 327 - 331
  • [5] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [6] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [7] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
    Dahlöf, B
    Sever, PS
    Poulter, NR
    Wedel, H
    Beevers, DG
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    [J]. LANCET, 2005, 366 (9489) : 895 - 906
  • [8] Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
    Ernst, ME
    Carter, BL
    Goerdt, CJ
    Steffensmeier, JJG
    Phillips, BB
    Zimmerman, MB
    Bergus, GR
    [J]. HYPERTENSION, 2006, 47 (03) : 352 - 358
  • [9] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    Hansson, L
    Lindholm, LH
    Ekbom, T
    Dahlöf, B
    Lanke, J
    Scherstén, B
    Wester, PO
    Hedner, T
    de Faire, U
    [J]. LANCET, 1999, 354 (9192) : 1751 - 1756
  • [10] Rationale and design of the avoiding cardiovascular events through combination therapy in patients LIving with Systolic hypertension (ACCOMPLISH) trial -: The first Randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension
    Jamerson, KA
    Bakris, GL
    Wun, CC
    Dahlöf, B
    Lefkowitz, M
    Manfreda, S
    Velazquez, EJ
    Weber, MA
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (09) : 793 - 801